BeOne Medicines (ONC) Other Non Operating Income (2015 - 2026)

BeOne Medicines (ONC) has reported Other Non Operating Income for 12 consecutive years, with $14.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non Operating Income rose 268.0% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at -$32.0 million (down 205.9% YoY), while the FY2025 annual figure was -$42.6 million, down 236.71% from the prior year.
• Other Non Operating Income climbed to $14.5 million in Q1 2026 per ONC's latest filing, from -$35.7 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $336.7 million in Q3 2023 and bottomed at -$129.6 million in Q2 2022.
• Historically, Other Non Operating Income has averaged $2.6 million across 5 years, with a median of $4.0 million in 2025.
• On a YoY basis, Other Non Operating Income climbed as much as 390.25% in 2022 and fell as far as 14850.06% in 2022.
• BeOne Medicines' Other Non Operating Income stood at $19.4 million in 2022, then fell by 13.83% to $16.7 million in 2023, then tumbled by 182.0% to -$13.7 million in 2024, then plunged by 159.87% to -$35.7 million in 2025, then jumped by 140.73% to $14.5 million in 2026.
• Business Quant data shows ONC's Other Non Operating Income at $14.5 million in Q1 2026, -$35.7 million in Q4 2025, and -$19.0 million in Q3 2025.